{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:13:58Z","timestamp":1788621238747,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,4]]},"DOI":"10.7759\/cureus.13691","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T13:34:21Z","timestamp":1614864861000},"source":"Crossref","is-referenced-by-count":1,"title":["Small-Cell Lung Cancer Cavities: Primary or Secondary?"],"prefix":"10.7759","author":[{"given":"Toufic","family":"Tannous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00060-07","article-title":"Cavitary pulmonary disease","volume":"21","author":"Gadkowski LB","year":"2008","unstructured":"Gadkowski LB, Stout JE. Cavitary pulmonary disease. Clin Microbiol Rev. 2008, 21:305-33. 10.1128\/CMR.00060-07","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.163.4.8092014","article-title":"Pulmonary aspergillosis: imaging findings with pathologic correlation","volume":"163","author":"Aquino SL","year":"1994","unstructured":"Aquino SL, Kee ST, Warnock ML, Gamsu G. Pulmonary aspergillosis: imaging findings with pathologic correlation. AJR Am J Roentgenol. 1994, 163:811-5. 10.2214\/ajr.163.4.8092014","journal-title":"AJR Am J Roentgenol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12150","article-title":"Fungal diseases mimicking primary lung cancer: radiologic-pathologic correlation","volume":"57","author":"Gazzoni FF","year":"2014","unstructured":"Gazzoni FF, Severo LC, Marchiori E, et al.. Fungal diseases mimicking primary lung cancer: radiologic-pathologic correlation. Mycoses. 2014, 57:197-208. 10.1111\/myc.12150","journal-title":"Mycoses"},{"key":"ref4","article-title":"Lung adenocarcinoma presenting with enlarged and multiloculated cystic lesions over 2 years","volume":"49","author":"Yoshida T","year":"2004","unstructured":"Yoshida T, Harada T, Fuke S, et al.. Lung adenocarcinoma presenting with enlarged and multiloculated cystic lesions over 2 years. Respir Care. 2004, 49:1522-4.","journal-title":"Respir Care"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2371041650","article-title":"Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome","volume":"237","author":"Onn A","year":"2005","unstructured":"Onn A, Choe DH, Herbst RS, et al.. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome. Radiology. 2005, 237:342-7. 10.1148\/radiol.2371041650","journal-title":"Radiology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-019-03064-1","article-title":"Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib","volume":"146","author":"Chen D","year":"2020","unstructured":"Chen D, Xu J, Zhao Y, et al.. Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib. J Cancer Res Clin Oncol. 2020, 146:401-6. 10.1007\/s00432-019-03064-1","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3182582912","article-title":"Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomes","volume":"7","author":"Phernambucq ECJ","year":"2012","unstructured":"Phernambucq ECJ, Hartemink KJ, Smit EF, Paul MA, Postmus PE, Comans EFI, Senan S. Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomes. J Thorac Oncol. 2012, 7:1271-5. 10.1097\/JTO.0b013e3182582912","journal-title":"J Thorac Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.2545","article-title":"Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer","volume":"27","author":"Crabb SJ","year":"2009","unstructured":"Crabb SJ, Patsios D, Sauerbrei E, et al.. Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer. J Clin Oncol. 2009, 27:404-10. 10.1200\/JCO.2008.16.2545","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.02.013","article-title":"Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical features","volume":"45","author":"Pentheroudakis G","year":"2004","unstructured":"Pentheroudakis G, Kostadima L, Fountzilas G, Kalogera-Fountzila A, Klouvas G, Kalofonos C, Pavlidis N. Cavitating squamous cell lung carcinoma-distinct entity or not? Analysis of radiologic, histologic, and clinical features. Lung Cancer. 2004, 45:349-55. 10.1016\/j.lungcan.2004.02.013","journal-title":"Lung Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32831089b2","article-title":"18F-fluoro-2-deoxy-D-glucose standardized uptake value in cavitating non-small-cell lung carcinoma","volume":"29","author":"Coffey JP","year":"2008","unstructured":"Coffey JP, Hill JC. 18F-fluoro-2-deoxy-D-glucose standardized uptake value in cavitating non-small-cell lung carcinoma. Nucl Med Commun. 2008, 29:1040-5. 10.1097\/MNM.0b013e32831089b2","journal-title":"Nucl Med Commun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e318168c7e9","article-title":"Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer","volume":"3","author":"Marom EM","year":"2008","unstructured":"Marom EM, Martinez CH, Truong MT, et al.. Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer. J Thorac Oncol. 2008, 3:351-7. 10.1097\/JTO.0b013e318168c7e9","journal-title":"J Thorac Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2016.03.121","article-title":"Cavity wall thickness in solitary cavitary lung adenocarcinomas is a prognostic indicator","volume":"102","author":"WatanabeY","year":"2016","unstructured":"WatanabeY, Kusumoto M, Yoshida A, Shiraishi K, Suzuki K, Watanabe SI, Tsuta K. Cavity wall thickness in solitary cavitary lung adenocarcinomas is a prognostic indicator. Ann Thorac Surg. 2016, 102:1863-71. 10.1016\/j.athoracsur.2016.03.121","journal-title":"Ann Thorac Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24559","article-title":"Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases","volume":"115","author":"Yan X","year":"2009","unstructured":"Yan X, Li M, Jiang M, Z L-Q, Luo F, Jiang Y. Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases. Cancer. 2009, 115:5018-25. 10.1002\/cncr.24559","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00188","article-title":"Invasive aspergillosis mimicking metastatic lung cancer","volume":"8","author":"Vanfleteren MJEGW","year":"2018","unstructured":"Vanfleteren MJEGW, Dingemans AMC, Surmont VF, et al.. Invasive aspergillosis mimicking metastatic lung cancer. Front Oncol. 2018, 8:188. 10.3389\/fonc.2018.00188","journal-title":"Front Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.100.2.554","article-title":"Localized Aspergillus infestation in primary lung carcinoma: clinical and pathological contrasts with post-tuberculous intracavitary aspergilloma","volume":"100","author":"Smith FB","year":"1991","unstructured":"Smith FB, Beneck D. Localized Aspergillus infestation in primary lung carcinoma: clinical and pathological contrasts with post-tuberculous intracavitary aspergilloma. Chest. 1991, 100:554-6. 10.1378\/chest.100.2.554","journal-title":"Chest"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2178925","article-title":"Invasive aspergillosis in a patient with stage III (or 3a or 3b) non-small-cell lung cancer treated with durvalumab","volume":"2019","author":"Gupta A","year":"2019","unstructured":"Gupta A, Tun A, Ticona K, Baqui A, Guevara E. Invasive aspergillosis in a patient with stage III (or 3a or 3b) non-small-cell lung cancer treated with durvalumab. Case Rep Oncol Med. 2019, 2019:2178925. 10.1155\/2019\/2178925","journal-title":"Case Rep Oncol Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-020-01960-5","article-title":"Pulmonary aspergillosis as a late complication after surgery for locally advanced non-small cell lung cancer treated with induction chemoradiotherapy","volume":"50","author":"Sugimoto S","year":"2020","unstructured":"Sugimoto S, Soh J, Suzawa K, et al.. Pulmonary aspergillosis as a late complication after surgery for locally advanced non-small cell lung cancer treated with induction chemoradiotherapy. Surg Today. 2020, 50:863-71. 10.1007\/s00595-020-01960-5","journal-title":"Surg Today"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4195-3","article-title":"E-cadherin mediates adhesion of Aspergillus fumigatus to non-small cell lung cancer cells","volume":"37","author":"Yan T","year":"2016","unstructured":"Yan T, Han J, Yu X. E-cadherin mediates adhesion of Aspergillus fumigatus to non-small cell lung cancer cells. Tumor Biol. 2016, 37:15593-9. 10.1007\/s13277-015-4195-3","journal-title":"Tumor Biol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader N","year":"2020","unstructured":"Howlader N, Forjaz G, Mooradian MJ, et al.. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020, 383:640-9. 10.1056\/NEJMoa1916623","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-003-0773-3","article-title":"Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"82","author":"Cornely OA","year":"2003","unstructured":"Cornely OA, B\u00f6hme A, Buchheidt D, et al.. Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2003, 82:186-200. 10.1007\/s00277-003-0773-3","journal-title":"Ann Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/53417-small-cell-lung-cancer-cavities-primary-or-secondary","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:03Z","timestamp":1707506703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/53417-small-cell-lung-cancer-cavities-primary-or-secondary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.13691","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,4]]}}}